Home / Stocks / OCX

OCX insider trading

Oncocyte Corp — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
11
Bought · 24 mo
$17.3M
Buys · last 90 days
0 · $0
Most recent buy
2025-02-11

Cluster buy detected

3 insiders bought OCX within a short window (2024-12-05→2025-01-31), $309k in total — cluster score 51/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-02-11James Andrea S.
Chief Financial Officer
Bought97,561$2.05$200k
2025-02-11SMITH PATRICK W
10% owner
Bought1,077,600$2.05$2.2M
2025-02-10BRADSHER NEAL C
10% owner
Bought5,165,695$2.05$10.6M
2025-02-04SMITH PATRICK Wcluster
10% owner
Bought915$2.01$2k
2025-01-31SMITH PATRICK Wcluster
10% owner
Bought4,198$2.01$8k
2025-01-15SMITH PATRICK Wcluster
10% owner
Bought16,055$2.12$34k
2024-12-27SMITH PATRICK Wcluster
10% owner
Bought90,219$2.13$192k
2024-12-26Arno Andrewcluster
Director
Bought12,500$2.11$26k
2024-12-09James Andrea S.cluster
Chief Financial Officer
Bought20,000$2.29$46k
2024-10-04James Andrea S.
Chief Financial Officer
Bought33,670$2.97$100k
2024-10-04BRADSHER NEAL C
10% owner
Bought1,315,339$2.95$3.9M

Most active insider buyers

InsiderRoleBuysTotal bought
BRADSHER NEAL C10% owner2$14.5M
SMITH PATRICK W10% owner5$2.4M
James Andrea S.Chief Financial Officer3$346k
Arno AndrewDirector1$26k

See OCX on the chart

Every insider buy and sell for OCX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.